SEC Form 3 · accession 0000105770-26-000106
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michel Lagarde
Officer — President and CEO · Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 10, 2026 · 3:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,850 | D |
Table II — derivative securities
No Table II lines on this filing.